Novo Nordisk reports data breach tells clinical trial patients to remain vigilant

Eric Sagonowsky reports As cybersecurity threats have proliferated across industries in recent years biopharma companies have emerged as prominent targets with intellectual property patient data and other sensitive information at stake Now Novo Nordisk is the latest drug giant to report a data breach In a Thursday incident notice Novo said it recently identified a security Source